Terms: = Uterine cancer AND CBLC, CBL-3, 23624, ENSG00000142273, RNF57, Q9ULV8, CBL-SL AND Prognosis
1 results:
1. Development of an immune gene prognostic classifier for survival prediction and respond to immunocheckpoint inhibitor therapy/chemotherapy in endometrial cancer.
Liu J; Chen X; Jiang Y; Cheng W
Int Immunopharmacol; 2020 Sep; 86():106735. PubMed ID: 32619957
[TBL] [Abstract] [Full Text] [Related]
